![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 20, 2015 9:40:06 AM
trading.jeff Sunday, 04/19/15 07:48:23 PM
Re: someconcerns post# 29519
Post # of 29527
$ONCS Merck has supplied its drug, Keytruda, to one of the trials that OncoSec is participating in. No doubt, Merck will be watching closely, as it will be watching the other trials in which Keytruda is being tested.
BTW, I came across this article in the WSJ re: Keytruda and melanoma:
Merck’s Keytruda Shows Improved Survival Odds in Melanoma
Immunotherapy displayed better survival rates compared with Bristol-Myers’s Yervoy
http://www.wsj.com/articles/mercks-keytruda-shows-improved-survival-odds-for-melanoma-patients-1429448169
The article is dated today but, wasn't there a trial, involving Keytruda, that was stopped early because Merck's drug showed promising results over a rival's drug? Isn't this article discussing the same?
All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM